-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Mereo BioPharma Group plc quarterly/annual Depreciation history and growth rate from Q1 2023 to Q2 2024.
- Mereo BioPharma Group plc Depreciation for the quarter ending June 30, 2024 was $100K, unchanged year-over-year.
- Mereo BioPharma Group plc annual Depreciation for 2023 was $171K, a 5.53% decline from 2022.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)